FDA Import Refusal SCS-0448533-8/10002/1 — Pfizer Limited
The FDA refused shipment SCS-0448533-8/10002/1 from Pfizer Limited (India) on Aug 31, 2026. The refused product falls under Drugs and Biologics — ANTI-INFLAMMATORY N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 31, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GCA99 ANTI-INFLAMMATORY N.E.C.
- Charges
- 75